RT-310 Dose Escalation BPH Study
Phase 1
Recruiting
- Conditions
- BPH (Benign Prostatic Hyperplasia)Lower Urinary Tract Symptoms
- Interventions
- Combination Product: RT-310
- First Posted Date
- 2023-11-18
- Last Posted Date
- 2024-11-13
- Lead Sponsor
- Resurge Therapeutics Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT06136819
- Locations
- 🇦🇺
Australian Clinical Trials, Wahroonga, New South Wales, Australia
🇦🇺Goldfields Urology, Bendigo, Victoria, Australia
🇳🇿Tauranga Urology Research, Tauranga, North Island, New Zealand
© Copyright 2025. All Rights Reserved by MedPath